GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Avelumab (Bavencio), IV injection

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Bavencio - labeled renal guidance

Product / population
Avelumab (Bavencio), IV injection
Renal method
Cockcroft-Gault CrCl, mL/min
Source revision
DailyMed SPL version 25, posted Sep 25, 2026
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Bavencio - product and source limitations

The analysis does not establish a dialysis dose. Review the product-specific toxicity precautions.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Bavencio - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Avelumab (Bavencio), IV injection

Renal method: Cockcroft-Gault CrCl, mL/min
Source date: DailyMed SPL version 25, posted Sep 25, 2026
Retrieved: 2026-11-07

Pharmacokinetic observation only. A drug-exposure observation is not itself a dose recommendation.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: Prescribing information, renal precautions and clinical pharmacology

In the population analysis, Cockcroft-Gault CrCl 15-89 mL/min had no clinically meaningful effect on the antibody's pharmacokinetics. The analysis does not establish a dialysis dose. Review the product-specific toxicity precautions.

RDM74-bavencio-official-1 · Source locator: Renal guidance: Prescribing information, renal precautions and clinical pharmacology

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cd725a1-2fa4-408a-a651-57a7b84b2118
Retrieved
2026-11-07
Renal-function method
Cockcroft-Gault CrCl, mL/min
Source date/version
DailyMed SPL version 25, posted Sep 25, 2026
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
a3b67ab8f3f5d28f6da022c4da850c3f786bb284bbff8e9356b2db9b5338303f

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=rx-bavencio&s1=RDM74-bavencio-official&h1=df79dddb109509aeb38e1933feeed41c981d40df8cd27762dd00ddaa87673957

Top